The recent approval of a new schizophrenia drug opens the door for newer, safer, and more efficacious treatment options without the unwanted side-effects.
The field of RNA therapeutics has expanded incredibly in the past 30 years, and mRNA-based COVID-19 vaccines were just the start.
Fifteen years of patient data has revealed an important link between hospital-acquired infections and seizure and epilepsy onset.
A blood test that accurately detects the ongoing effects of sport-related concussion has the potential to help pinpoint when a player can safely return.
The finding arose from long-term follow-up of patients who received human growth hormone that was taken from brain tissue of deceased donors, but the risk is very low – and you can’t “catch” it like a virus.
A recent study from Sweden found people with a history of chronic stress or depression had a heightened risk of developing Alzheimer’s disease.
The drug donanemab is being hailed as a turning point in the fight against Alzheimer’s, following a global trial that confirms it can slow cognitive decline.
A new research program will target biological causes and possible treatments, including anti-psychotic drugs, brain stimulation and hormones.
As Alzheimer’s cases grow, scientists have been deep in debate over its causes. Now, with treatments are on the horizon, the new race is to ready the health system.
German doctors have reported success in treating patients with severe lupus, using cell treatments like those used for some forms of blood cancer.
There’s no one “thing” we can blame for causing dementia, and why it’s so hard to find that silver bullet to stop it – particularly at older ages.
Researchers are delving into a protein with the potential to stop habitual drinking.
If there's ever been a time for a paradigm shift in the way we conceptualise mental health and treat mental illness, it's now.
It’s been described as feeling like your brain is on fire, and can be characterised by delusions and hallucinations. But those with autoimmune encephalitis aren’t crazy, they’re ill.
Although a great deal of research is still required, it may one day be possible to identify and treat people suffering from CTE, or at risk of it.
Research into snake venom pivoted from Alzheimer's disease to COVID-19 when the coronavirus reared its head.
Dummy text
